Tumor‐Targeted Exosome‐Based Heavy Atom‐Free Nanosensitizers With Long‐Lived Excited States for Safe and Effective Sono‐Photodynamic Therapy of Solid Tumors
Authors:
Open Access
- 1 April 2025
- journal article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (18) , e2500927
Abstract
Theranostic nanosensitizers with combined near‐infrared (NIR) fluorescence imaging and sono‐photodynamic effects have great potential for use in the personalized treatment of deep‐seated tumors. However, developing effective nanosensitizers for NIR fluorescence image‐guided sono‐photodynamic therapy remains a considerable challenge, including the low generation efficacy of reactive oxygen species (ROS), poor photostability, and the absence of cancer specificity. Herein, a novel heavy atom‐free nanosensitizer is developed, which exhibits intense NIR fluorescence, high ROS generation efficiency, and improved aqueous stability. By conjugating a bulky and electron‐rich group, 4‐(1,2,2‐triphenylvinyl)‐1,1′‐biphenyl (TPE), to the IR820 backbone, the resulting IR820 bearing TPE (IR820‐TPE) effectively generates ROS via type I and II photochemical mechanisms under 808 nm laser irradiation. Moreover, TPE conjugation considerably increases the sono‐photodynamic performance of IR820. To improve the intracellular delivery and tumor‐targeting ability of IR820‐TPE, biotin‐conjugated exosome (B‐Exo) is used as a natural nanocarrier. In vitro studies demonstrate the outstanding therapeutic performance of IR820‐TPE‐loaded B‐Exo (IR820‐TPE@B‐Exo) in synergistic sono‐photodynamic cancer therapy. In vivo studies reveal that IR820‐TPE@B‐Exo shows enhanced tumor accumulation, strong fluorescence signals, and effective sono‐photodynamic therapeutic activity with high biosafety. This work demonstrates that IR820‐TPE@B‐Exo is a promising sono‐phototheranostic agent for safe and targeted cancer therapy and NIR fluorescence imaging.Keywords
Funding Information
- National Research Foundation of Korea (2022H1D3A2A01096309)
- National Research Foundation of Korea (2022R1A2C1007207)
- National Research Foundation of Korea (NRF‐RS‐2023‐00244402)
This publication has 54 references indexed in Scilit:
- Engineering Macrophage‐Derived Exosome to Deliver Pirfenidone: A Novel Approach to Combat Silicotic Pulmonary Fibrosis (Adv. Healthcare Mater. 4/2025)Advanced Healthcare Materials, 2025
- Heptamethine Cyanine‐Based Nanotheranostics with Catalase‐Like Activity for Synergistic Phototherapy of CancerAdvanced Functional Materials, 2023
- Piezocatalytic 2D WS2 Nanosheets for Ultrasound‐Triggered and Mitochondria‐Targeted Piezodynamic Cancer Therapy Synergized with Energy Metabolism‐Targeted ChemotherapyAdvanced Materials, 2023
- Phototheranostic Agents Based on Nonionic Heptamethine Cyanine for Realizing Synergistic Cancer PhototherapyAdvanced Healthcare Materials, 2023
- Amino‐Acid‐Encoded Supramolecular Photothermal Nanomedicine for Enhanced Cancer TherapyAdvanced Materials, 2022
- Enhancing Penetration Ability of Semiconducting Polymer Nanoparticles for Sonodynamic Therapy of Large Solid TumorAdvanced Science, 2022
- A Self‐Degradable Conjugated Polymer for Photodynamic Therapy with Reliable Postoperative SafetyAdvanced Science, 2021
- Photosensitizers for Photodynamic TherapyAdvanced Healthcare Materials, 2019
- Recent Progresses in Phototherapy‐Synergized Cancer ImmunotherapyAdvanced Functional Materials, 2018
- Beyond Phototherapy: Recent Advances in Multifunctional Fluorescent Nanoparticles for Light‐Triggered Tumor TheranosticsAdvanced Functional Materials, 2018